Cynata Therapeutics has received positive data from a proof-of-concept study of its Cymerus mesenchymal stem cells (MSCs) in an experimental model of asthma. [ + ]

Melbourne researchers have developed a way to radically miniaturise a magnetic resonance imaging (MRI) machine using atomic-scale quantum computer technology. [ + ]

CSL has announced the inaugural recipients of its Centenary Fellowships, established to support Australia's best and brightest biomedical researchers. [ + ]

Xperential Scientific is a newly established scientific instrumentation, consumable, software and diagnostic supplier based in Melbourne. [ + ]

Japanese researchers have shown that they can prevent protein synthesis reactions from taking place using a photoresponsive molecular cage. [ + ]

Fycompa, a once-daily epilepsy treatment, is now available in Australia for adjunctive treatment of primary generalised tonic-clonic (PGTC) seizures in adults and adolescents with idiopathic generalised epilepsy. [ + ]

Bill Ferris AC, chair of Innovation and Science Australia, has called for greater collaboration between Australian businesses and our publicly funded research institutions. [ + ]

From 24–27 October 2016, Melbourne Convention Centre will play host to International BioFest — a series of three major life sciences conferences taking place at the one time. [ + ]

The University of Melbourne's Bio21 Institute has announced a major collaborative agreement with Thermo Fisher Scientific, a world leader in serving science through the development and provision of cutting-edge technology. [ + ]

BioScience Managers has announced the launch of a new venture capital fund for Australia's innovative healthcare and biomedical research sectors. [ + ]

Australian and French scientists are developing a new potential way to detect and monitor breast cancer that could involve a simple blood test. [ + ]

OneVentures will lead a $15 million funding round for a promising new treatment for peanut allergy in children, developed at the Murdoch Childrens Research Institute. [ + ]

Allied Market Research has projected that the global defibrillator market will reach $15.61 billion by 2022. [ + ]

US and Australian scientists have developed a new method to estimate weakness in the Earth's outer layers. Their work will help explain and predict volcanic activity and earthquakes at a much smaller scale than previously possible. [ + ]

Australian scientists have identified a new type of immune cell that stays in the liver — liver-resident immune cells — guarding against malaria infection. [ + ]